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Cell transplantation therapy has long been investigated as a therapeutic intervention for 
neurodegenerative disorders, including spinal cord injury, Parkinson’s disease and 
amyotrophic lateral sclerosis. Indeed, patients have high hopes for a cell-based therapy. 
However, there are numerous practical challenges for clinical translation. One major 
problem is that only very low numbers of donor cells survive and achieve functional 
integration into the host. Glial scar tissue in chronic neurodegenerative disorders strongly 
inhibits regeneration and this inhibition must be overcome to accomplish successful cell 
transplantation. Intra-neural cell transplantation is considered to be the best way to deliver 
cells to the host. We have questioned this view with experiments in vivo on a rat glial scar 
model of the auditory system. Our results show that intra-neural transplantation to the 
auditory nerve, preceded by chondroitinase ABC (ChABC)-treatment, is ineffective. 
There is no functional recovery and almost all transplanted cells die within a few weeks. 
However, when donor cells are placed on the surface of a ChABC-treated gliotic auditory 
nerve, they autonomously migrate into it and recapitulate glia- and neuron- guided cell 
migration modes to repair the auditory pathway and recover auditory function. “Surface 
transplantation” may thus pave the way for improved functional integration of donor cells 
into host tissue, providing a less invasive approach to rescue clinically important neural 
tracts.  
 




Cell transplantation can restore function in neurodegenerative disorders but the low rate 
of functional integration of donor cells into host is a major limiting factor for clinical 
application. This is closely related to the long-standing view that donor cells must be 
transplanted intra-neurally. We show that glial scar, which is common in 
neurodegenerative conditions, inhibits the survival of intra-neurally transplanted cells in 
our rat glial scar model in the auditory system. However, cells placed on the “surface” of 
scar tissue autonomously enter the nerve and become functionally integrated into the host. 
The glial scar, normally considered to be a barrier to cell transplantation, includes 
important structural and chemical cues that are disrupted by intra-neural delivery but 






Cells transplanted into the nervous system could cure various forms of neurodegenerative 
disease and neural injury (1, 2) but most donor cells die without functional integration (3) 
and glial scar tissue is strongly inhibitory to axon regeneration (4). Glial scar tissue forms 
following conditions such as ischemia or mechanical trauma when reactive astrocytes 
increase proliferation, become hypertrophic and up-regulate glial fibrillary acidic protein 
(GFAP) (5, 6). In this study, however, we demonstrate that if donor cells are delivered 
appropriately, they can interact successfully with the glial scar and restore lost neuronal 
function. We developed an in vivo model of the chronic gliotic environment in clinical 
patients by compressing the rat auditory nerve without breaching the fluid spaces that 
contain the sensory structures inside the cochlea (7-10). In this model, spiral ganglion 
cells (the auditory neurons) degenerate selectively but hair cells are preserved both 
morphologically and functionally (7, 8, 10, 11). We then waited 5 weeks before cell 
transplantation to allow the formation of a glial scar with the progressive degeneration of 
auditory neurons. We characterized the glial scar with several experimental measures. 
This is an important element because experimental models for cell-based therapies for 
neurodegenerative diseases should include the chronic gliotic environment to simulate 
the appropriate clinical condition in patients. 
To compress the auditory nerve, the CNS portion was atraumatically exposed in the 
cerebellopontine angle cistern through right suboccipital craniectomy, a nerve hook was 
placed into the internal auditory meatus and the nerve was injured by a single compression 
(Fig. 1A-B, S1A). We used a murine auditory neuroblast cell line for transplantation 
(US/VOT-N33) (12). This cell line was derived from the ventral otocyst (inner ear anlage) 
of a mouse embryo at embryonic day ED10.5 and was selected because it expresses key 
markers for auditory sensory neurons and differentiates with the appropriate bipolar 
morphology in the ear both in vitro and in vivo (11, 12). 
In the first experiments we delivered cells into the auditory nerve via a thin fused silica 
tube (Fig. S1B), treating the nerve topically with chondroitinase ABC (ChABC) (13) 
soaked in gelatin sponge at the time of nerve injury and then again immediately after cell 
transplantation. Three months later we assessed the structural and functional recovery of 
the auditory nerve.  
During these experiments we noticed that donor cells that spilled onto the surface of 
the nerve were apparently able to enter the ChABC-treated tissue and to survive. Thus we 
reasoned that cell delivery onto the surface of the glial scar might be successful and less 
invasive. In this context we designed an experiment to compare two methods of cell 
delivery. In the first we applied the conventional method of intra-neural infusion and in 
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the second we delivered cells to the surface of the nerve without mechanical damage to 
its structure. We then compared the results in terms of cell morphology and functional 




An auditory system model of the glial scar. The CNS portion of normal auditory nerve 
is relatively long compared with other cranial nerves and it projects into the auditory 
nerve trunk (14). The transitional zone between the PNS and the CNS lies within the 
temporal bone, distal to the internal auditory meatus (Fig. 1A) (15). It is defined by the 
boundary of the expression of GFAP, which is expressed only by the astrocytes in the 
CNS (Fig. 1A-B left). Following compression, numerous changes occur that are 
characteristic of glial scar formation and that we confirmed in our model. 
We first characterized the glial scar with antibodies to GFAP (6), which showed that 
compression in one ear led to thinning of the auditory nerve and extension of the GFAP 
domain peripherally (Fig. 1B). Glial scar processes were observed to pass through 
Rosenthal’s canal toward the habenula perforata through which the distal auditory 
neurons reach the hair cell regions (Fig. 1C). Immunofluorescence for GFAP was 
increased relative to the sham ear (Fig. 1D). The levels of GFAP protein in the compressed 
tissue were higher than in the sham operated ear (Fig. 1E) and the corresponding levels 
of mRNA expression were significantly higher after 1, 4 and 25 weeks (Fig. 1F). 
Immunofluorescence and mRNA for neurocan, a class of chondroitin sulfate 
proteoglycans (CSPGs) that are predominantly produced by reactive astrocytes and that 
inhibit regeneration in the CNS (16), increased significantly (Fig. 1G-H). Finally, mRNA 
for nestin, which is another hallmark of reactive gliosis (5, 6), increased significantly 4 
weeks after compression (Fig. 1I) and nestin-positive glial scar processes were observed 
mainly at the compression site (Fig. 1J). Treatment of compression-induced glial scars 
with ChABC was evaluated using the monoclonal antibody 2B6, which provides a 
measure of CSPG digestion (13). Five weeks after compression with ChABC treatment 
the antibody strongly labelled the scar, demonstrating effective digestion of CSPGs (Fig. 
1K).  
 
Functional recovery following cell transplantation. In our animal surgery, the lateral 
part of the cerebellum was removed to fully expose the auditory nerve, inevitably 
resulting in a substantial change of bioelectric volume conductor around the auditory 
nervous system. Therefore, there was little value in comparing the ABR before surgery 
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with that after a large volume of the cerebellum was removed. Hence, we compared ABRs 
immediately before cell transplantation (5 weeks after auditory nerve compression) and 
3 months after cell transplantation as there was no substantial volume change around 
auditory nervous system in these two stages.  
There was no improvement in the auditory evoked brainstem responses (ABR) after 3 
months in any of the 20 animals in which cells were delivered by intra-neural 
transplantation to ChABC-treated, gliotic auditory nerves (Fig. 2A-C, S1B). Positive, 
monophasic potentials (“cut end potentials” (17)) indicated that sound-induced electrical 
activity did not pass the transplantation site. However, ABRs improved in 10 of the 17 
animals in which cells were delivered by surface transplantation (Fig.2D-F; Fig. S1B). 
In the ABRs, waves I and II represent activity in the auditory nerve and cochlear nucleus, 
respectively (18) (Fig. S2A-B) but they were attenuated by the direct mechanical injury 
and glial scar formation (Fig. S2C). Thus we evaluated function by measuring wave III, 
which originates in the contralateral superior olivary complex (SOC), more central than 
the origins of wave I and II (Fig. S2A). Its amplitude reflects activity entering the SOC 
via the cochlear nucleus and auditory nerve. There were significant improvements in 
wave III amplitude and threshold (Fig. 2D-H, Table S1A-B). Latency analysis revealed 
that conduction velocity recovered in the 16 kHz region but not in the 4 and 8 kHz regions 
(Fig. 2I, Table S1C). This may be because the 16 kHz region was nearest to the 
transplantation site, allowing more time for myelination, so a similar recovery might have 
occurred at 4 and 8 kHz over a longer period. In the sham rats to which medium-soaked 
gelatin sponge and fibrin glue were placed on the nerve (n=5), no significant changes in 
the ABRs were observed 3 months later, indicating that spontaneous recovery did not 
occur 5 weeks after auditory nerve compression. 
 
Integration of donor cells to the auditory nerve. We observed no evidence of 
significant cell survival or integration after 3 months in any of the 20 animals in which 
cells were delivered by intra-neural transplantation to ChABC-treated gliotic auditory 
nerves. Furthermore, there was clear evidence of cell debris from the donor cells within 
the nerve (Fig. 3A-B). In stark contrast, cells transplanted on the surface of the glial scar 
did not die but survived attached to the surface of the auditory nerve and the brainstem 
(Fig. 3C-D). There was evidence that groups of at least 15-20 cells had entered the 
auditory nerve 3 months after cell transplantation (Fig. 3E). In some cases the cells 
appeared to migrate into the nerve in a chain formation (Fig. 3F-G) or aligned within 
conduit-like structures in the glial scar (Fig. 3H-I). Transplanted cells that entered the 
proximal portion of the glial scar appeared to be guided by hypertrophic astrocytic 
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processes and migrated distally within the scar (Fig. 3J-M). 
Inside the nerve, transplanted cells were closely associated with GFAP+ processes (Fig. 
4A-B), reminiscent of glia-guided migration of newborn neurons in the developing cortex 
(19, 20). Astrocytes at the lesion appeared to lose their stellate morphology and to adopt 
overlapping, elongated morphologies (21) (Fig. 4C). Among them, the transplanted cells 
were often organized in chains within the elongated GFAP+ processes (Fig. 4D-E). This 
behavior resembles the rostral migratory stream (RMS) where neuroblasts migrate within 
a tube-like structure, ensheathed by specialized GFAP+ astrocytes (22, 23).  
Neurons can use existing axons for guidance (24), which seemed to be reiterated in our 
study (Fig. 4F). We found numerous donor cells attached to residual neurons (Fig. 4G-
H) and with lengthy GFP+ projections (Fig. 4I). Residual neurons seemed to provide a 
scaffold in the core of dense anisomorphic glial scar tissue where thick GFAP+ glial scar 
processes lost their longitudinal orientation (Fig. 4J-M). 
 
Synaptic connections at the proximal and distal ends of the auditory nerve. The ABR 
results imply that cells transplanted to the nerve surface form synapses both with hair 
cells and with neurons in the cochlear nuclei in the hindbrain. Evidence for such 
connections has been shown previously in a sub-acute model of cell therapy in the 
auditory system  (25). We observed bundles of neurites expressing eGFP in Rosenthal’s 
canal to the habenula perforata (HP, foramina nervosa) (Fig. 5). More specifically, at the 
basal and perinuclear regions of inner hair cells we found eGFP labelling co-localized 
with punctate labelling for the glutamate receptor sub-units GluR2/3 (26) (Fig. 6A). This 
provides strong evidence for innervation of hair cells by projections from the donor cells, 
particularly because postsynaptic glutamate receptors do not survive loss of auditory 
afferent neurons without cell transplantation (27).  
In our experimental model, the PVCN (posteroventral cochlear nucleus) is affected 
most, the DCN (dorsal cochlear nucleus) less and the AVCN (anteroventral cochlear 
nucleus) was not affected (8). Hence, to most clearly evaluate how the transplanted cells 
re-innervate cochlear nucleus cells, we chose to evaluate the PVCN. We observed GFP+ 
process projecting towards the CN (Fig. 6B) and in animals with improved ABRs, eGFP 
and synaptophysin were co-localized in significantly larger numbers of ovoid cells, which 
were probably globular bushy cells, than in those without ABR improvements (Fig. 6C-
D). The survival of CN cells depends on input from auditory neurons, so the cochlear 





Correlation between cell survival and functional recovery. We saw no functional 
recovery or cell survival with intra-neural transplantation. With surface transplantation 
we observed recovery of the ABRs in 10 of 17 animals treated. In those 10 animals the 
number of detectable donor cells after 3 months was significantly higher than in the 
remaining 7 (Fig. 7A-D) but the residual numbers of endogenous spiral ganglion cells 
was similar (Fig. 7E-F). This result provides strong evidence that the transplanted cells 
contributed to the observed improvements of wave III amplitudes, thresholds and 
conduction velocity. It also reveals a striking difference between the two methods of cell 
delivery, with greater functional recovery being linked to the less invasive method of 
surface transplantation. 
 
Cues for inward migration of surface cells. The cues that guide the migration of 
transplanted cells are unknown. However, in our model the hair cells remain intact (10) 
and they should provide a source of neurotrophins, notably BDNF and NT-3, which are 
indispensable for the maintenance and survival of auditory neurons (28). Correspondingly, 
auditory neurons express the relevant receptors, trkB and trkC, respectively (28). We 
found that BDNF concentrations were higher in ChABC-treated tissue (Fig. 8A) and that 




We show that in our auditory nerve model, cells delivered to the surface of ChABC-
treated glial scars can migrate into the nerve, extend neuritic processes and form synaptic 
connections to their peripheral and central targets. This is associated with significant 
functional recovery of the auditory pathway. In contrast, cells delivered by intra-neural 
infusion die without either integration or functional recovery. Most experiments in cell 
transplantation and axon regeneration have been performed soon after injury and before 
the glial scar has developed (13, 29, 30). Our transplantation model is designed to reflect 
the clinical situation in terms of damage, glial scar formation and subsequent surgery. In 
this model, changing the degree of compression provides a wide range of reproducible 
nerve injury as observed in human neurodegenerative diseases.  
 Our results suggest that the glial scar contains critical structural and chemical cues that 
should be preserved during transplantation. Intra-neural delivery either destroys those 
cues or places the cells immediately into a hostile cellular environment that does not allow 
them to engage with the tissue. In human neurodegenerative diseases, pathological 
processes progress chronically but numerous axons remain functional even at advanced 
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stages (31). Infusion pressure and the infused cell mass during surgery may damage these 
residual neurons. Moreover, intra-neural damage may re-activate the process of glial scar 
formation again as observed in surgical removal of glial scar tissue (32). In contrast, 
surface delivery may enable cells to make appropriate adaptations to the tissue matrix to 
ensure that they survive once they migrate into the nerve. We show that BDNF could be 
an important guidance and survival factor in our model. The relatively higher survival 
rate (13.7%) of the transplanted cells in this experiment may have been due to the delivery 
site, where there were appropriate cues from the sensory epithelium and nutrients from 
the cerebrospinal fluid. The removal of CSPG side chains by ChABC might facilitate the 
diffusion of BDNF through the nerve from the hair cells (33) and the gradient might be 
preserved better without damage by intra-neural intervention. Nevertheless, there are 
many other soluble signaling molecules that could be important. Furthermore, there are 
numerous intercellular interactions, mediated by molecules such as N-cadherin and 
NCAM, which play a crucial role in regenerating and directing axons (34). In a study 
where dorsal root ganglion neurons were seeded onto organotypic slices containing the 
corpus callosum, the donor neurons regenerated lengthy axons along the processes of 
gliotic astrocytes, and fibronectin expressed on the surface of the astrocytes was an 
important factor for this regeneration (35). Intriguingly, donor cells appeared able to jump 
from one astrocytic process to another (35). Such cues are likely to be important for 
integration of transplanted cells in our model.  
The structure of the scar is likely to be critical for the integration of transplanted cells. 
In our study, glial processes projected distally into the small bony canals beyond the 
fundus of the internal auditory canal and this phenomenon was observed equally in 
animals with and without ChABC treatment (Fig. 1B right, 1C, 3A), indicating ChABC 
did not change the basic framework of the glial scar as far as we can judge from the GFAP 
immunohistochemistry. However, ChABC apparently aided the donor cells to efficiently 
exploit preserved positive cues because it digests glycosaminoglycan (GAG) chains of 
CSPGs and removes their inhibitory influence (36). GAG chains of CSPGs interact with 
inhibitory neuronal receptors, including receptor protein tyrosine phosphatase sigma 
(RPTPσ), leukocyte common antigen-related (LAR) phosphatase and Nogo receptors 1 
and 3 (NgR1, 3), preventing axon regeneration (29, 30, 36). In addition to such receptor-
mediated mechanisms, it was recently demonstrated that ChABC modifies the immuno-
inflammatory process of the injured CNS (37, 38). Macrophages have two distinct 
polarized phenotypes, M1 and M2, depending on the local tissue environment (39). In the 
acute stage of spinal cord injury, pro-inflammatory M1 macrophages dominate the lesion 
but during the resolution stage they are replaced by anti-inflammatory M2 macrophages 
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(40). M2 macrophages produce anti-inflammatory cytokines including IL-10 (40) and 
several in vivo experimental studies indicate IL-10 promotes recovery after spinal cord 
injury (41, 42). Recently, it was demonstrated viral overexpression of ChABC induced 
anti-inflammatory M2 macrophage polarization (37) accompanied with increased 
expression of IL-10, resulting in reduced tissue loss in rat spinal cord injury (38). 
Following spinal cord injury in amphibians and fish, glial (astrocytic) bridges span the 
injury site and guide neuritic growth, resulting in remarkable functional recovery (43). 
Experimentally, many cells, matrices and nerve grafts have been investigated as the 
bridge to fill the lesion in mammals (44). In this context, it is reported that immature 
astrocytes injected along with ChABC are capable of forming the bridge-building process 
beyond the gliotic lesion in the adult rat cingulum, probably through a matrix 
metalloproteinase-2 (MMP-2) dependent mechanism (44). In our study a “glial scar 
bridge” was effectively formed from endogenous astrocytes (Fig. 1B right, 1C), which 
may have helped to guide donor cells and to support neurite elongation. In cell 
transplantation, the transition zone between the CNS and PNS (Fig. 1A) can be a 
significant barrier for cell migration and neurite extension (45). However, this may be 
overcome by the formation of glial scar bridge. 
Neuron-guided cell migration may also be important. We observed residual neuronal 
elements in glial scar tissue that lacked parallel alignment of glial processes and these 
residual neurons were used by the donor cells as the scaffold (Fig. 4J-M). Hence, delayed 
clearance of myelin debris, uniquely observed in CNS degeneration and regarded as an 
inhibitory factor for axon regeneration (46), is not necessarily disadvantageous for donor 
cells in cell transplantation therapy (35, 44). Taken together, transplanted cells seem to 
utilize complementary structural and chemical guidance cues from both neurons and glial 
cells, depending on the environment surrounding them (Fig. 4). 
Survival, differentiation and integration of donor cells depend on their molecular 
programs and their ability to respond to the host environment (47). Our donor cells were 
region-restricted precursor cells at a relatively late stage of inner ear development (12). 
Precursor cells have numerous advantages over less committed, proliferating progenitors 
because precursors with defined transcription factors expressed at a specific ontogenetic 
stage have more chance to be integrated into the host than progenitor or stem cells that 
have not yet begun to express such factors (48).  
Cell therapy for neuronal regeneration is an ambitious goal in restorative medicine and 
numerous practical steps must be addressed for effective clinical translation. In our 
experiments, the average improvement of ABR thresholds was about 10 dB SPL (Fig. 
2E-F, H), which is clinically relevant because serviceable function can be achieved with 
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a relatively small number of functional neurons. With only 5-10% of the total axonal 
population, patients with cochlear implant are able to hear (49). Coincidentally, a similar 
value of functional motor neurons can enable patients to become mobile (50). Thus, we 
believe that surface transplantation is a less invasive technique that could have more 
widespread application to the nervous system. In amyotrophic lateral sclerosis (ALS), 
anterior horn cells and axons often degenerate (51). Suitable donor cells applied on the 
surface of degenerated anterior roots of the spinal cord could provide a minimally 
invasive method of cell transplantation to restore lost function of the motor neurons. 
Similarly, surface transplantation of appropriate motor neuron precursors may ameliorate 
neurological deficit due to poliomyelitis in which anterior horn cells degenerate (52). 
Patients with neurological sequelae from peripheral neuropathy with spinal cord or 
brainstem involvements may also be candidates for surface transplantation (53). We 
demonstrated that elongated, astrocytic processes after trauma played a crucial role in cell 
migration (Fig. 4A-E) and intriguingly similar elongated processes in reactive astrocytes 
are observed in multiple sclerosis (54). Since we observed neurites from transplanted cells 
in the cochlear nucleus, surface transplantation may be applied not only to neural systems 
in the superficial layers of the nervous system but also to those in deeper locations. This 
could include the substantia nigra and the caudate nucleus, which may be approachable 
via cisternal and intraventricular routes.  
In conclusion, the glial scar has been regarded as a major barrier for cell transplantation 
therapy but we show that this is not necessarily the case if donor cells are applied 
appropriately to the host with minimal tissue damage. Our method of surface 
transplantation potentially opens the way to more efficient and less invasive approaches 
for cell transplantation in many forms of CNS and PNS disorders.  
  
Materials and Methods 
 
Glial scar induction in rat auditory system by mechanical compression to auditory 
nerve.  
Animal experiments were conducted in accordance with the Guidelines for Animal 
Experiments at Kyoto University. Exposing of the auditory nerve of male Sprague-
Dawley rats (P7-8 weeks) was performed as previously reported (7, 8, 10, 11). For 
compression, a nerve hook (tip diameter: 0.15 mm, No. 10140-03, Fine Science Tools, 
Canada) with the tip bent at a 150-degree angle was placed onto the auditory nerve at the 
internal auditory meatus and the nerve was mechanically injured by a single compression 





To treat the nerve topically with enzyme we applied a piece of absorbable gelatin sponge 
(2.0 mm3) (SpongelⓇ, Astellas Pharma) soaked in 20µL (0.2U) of chondroitinase ABC 
(Seikagaku, Sigma-Aldrich), first at the time of nerve injury and second, immediately 
after cell transplantation. Five weeks after auditory nerve mechanical injury, we re-
opened the operative site and inserted a fused silica tube (external and internal diameter, 
105 µm and 40 µm, respectively, Eicom, Japan) into the auditory nerve trunk (Fig. S1B). 
For surface transplantation, we placed a fused silica tube approximately 500 μm away 
from the surface of auditory nerve in the cerebellopontine angle cistern (Fig. S1B). In 
both experiments, we applied another ChABC-soaked gelatin sponge and covered the site 
with fibrin glue (Beriplast-P Combi-setⓇ, CSL Behring; BolhealⓇ, Kaketsuken). We then 
infused 17,500 ± 2,400 cells (average ± SD) in 2μL of high concentration MatrigelⓇ (BD), 
with bFGF (Peprotech, 25 ng/mL) that aids cell differentiation (12), using a microinjector 
(Micro 4, World Precision Instruments) with an infusion speed of 1,000 nL/min. Valproic 
acid (Wako, Japan) was orally administered in drinking water (480 mg/kg body 
weight/day), to enhance neurite extension (55), from one week before cell transplantation 
until the day of perfusion/fixation for 18 weeks. 
 
Immunohistochemistry 
Temporal bones were obtained and processed as reported (7, 8, 10, 11). The section angle 
was chosen so that the auditory nerve trunk, posteroventral (PVCN) and dorsal cochlear 
nucleus (DCN) were simultaneously included in one section as fully as possible by 
reference to Fig. 1 and 2 in Hackney et al (56). Primary antibodies used in the current 
study are listed in SI Methods and Fig. S1C. 
 
Quantification of immunofluorescence intensity 
Images were obtained with identical confocal microscope and microscope settings 
throughout capturing of images; the fluorescence intensities of GFAP in sham and 
experimental samples were compared at the same threshold (n=4). In 1G2 and 2B6 
antibodies, the fluorescence intensity in sham samples was manually reduced to 
approximately zero level and at this level the images of experimented specimens were 
photographed (n=4). Images were converted into grey scale images with Photoshop (CS3, 
Adobe), transferred to NIH Image J and positive pixel area (P.P.A.) was analysed 




Western blotting of GFAP 
Samples were collected from experimental rats, 4 weeks after compression (right side, 
n=19) and those from sham rats were used as control. After processing, proteins were 
separated on a SuperSep Ace gel (Wako) and transferred into PVDF membrane (GE 
Healthcare). Membranes were probed with GFAP antibody (1:15,000, Dako, rabbit 
polyclonal) overnight and horseradish peroxidase-linked anti-rabbit IgGs (1:10,000, GE 
Healthcare) were applied as the secondary antibody. GAPDH was used as a loading 
control. Detailed information is listed in SI Methods. 
 
qRT-PCR 
The samples were collected from the rats 1, 4, and 25 weeks after compression (15 rats 
for each time point). Total RNA was extracted using an RNeasy Mini Kit (Qiagen). 
Single-stranded cDNA was synthesized with a High Capacity cDNA synthesis kit 
(Applied Biosystems). Real-time PCR primers and probes were obtained from Applied 
Biosystems (CSPG3, Neurocan, Rn00581331_m1; GFAP, Rn00566603_m1; Nestin, 
Rn00564394_m1). The data were acquired in triplicate. Gene expression values, 
normalized to GAPDH expression, were determined by using the comparative Ct method 
(ΔΔCt method). Detailed information is listed in SI Methods. 
 
ELISA 
Samples collected from 30 rats (5-10 weeks after compression) were processed after 
Elfving et al (57). ELISA study was performed with a Promega BDNF Emax 
ImmunoAssay System following the manufacturer’s instructions. Detailed information is 
listed in SI Methods. 
 
Counting of spiral ganglion cells, transplanted cells and cochlear nucleus cells 
In 4 sham rats, 6 rats with ABR improvement and 4 rats without ABR improvement, we 
counted the numbers of spiral ganglion cells with nuclei in Rosenthal’s canal in the basal 
cochlear turn (approximately corresponds to 70-100% of entire cochlear length from the 
cochlear apex), middle turn (70-30%) and apical turn (-30%) (58) in every 4th section in 
each rat. In the latter 2 groups of the rats, GFP+ transplanted cells were counted. For 
quantification of cochlear nucleus cells, we chose a section that included auditory nerve 
root, PVCN and DCN most widely among the sections and counted cells with 
synaptophysin+ endbulbs in sham rats and those with GFP+ synaptophysin+ endbulbs in 
experimental rats, in 5 randomly selected regions that approximately evenly covered 
entire PVCN (each region size, 270 x 270 μm) in each animal (5 rats with ABR 
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improvement; 4 rats without ABR improvement).  
 
ABR recording 
We recorded tone burst ABR three times in each animal, before auditory nerve injury, 5 
weeks after nerve injury before cell transplantation and 3 months after cell transplantation 
as previously reported (59). White noise (40 dB) was applied to the contralateral ear to 
prevent the contribution from non-tested ear. We measured wave III amplitude as shown 
in Fig. S2C at 85 dB SPL in 8 and 16 kHz and 75 dB in 4 kHz to avoid large cochlear 
microphonics in 85 dB in this frequency. 
 
Statistical analysis 
Unpaired or paired Student’s two-tailed t-test was performed using Excel 2013 
(Microsoft). For all statistical tests P<0.05 was used as the criterion for statistical 
significance. In all figures, error bars indicate one standard deviation. 
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Figure 1. Glial scar formation after auditory nerve compression. (A) The CNS 
portion (CNS-P) of the normal auditory nerve protrudes into the auditory nerve trunk and 
the transitional zone (TZ) at the boundary with the PNS is within the internal auditory 
canal (IAC). Mechanical compression (red arrow) applied to the CNS-P induced a glial 
scar. The red circle corresponds to that in Fig. S1A. BS, brainstem; CN, cochlear nucleus; 
Fs, fundus of the internal auditory canal; HC, hair cell; HP, habenula perforata; IAM, 
internal auditory meatus; PNS-P, PNS portion of the auditory nerve; SGC, spiral ganglion 
cells. (B) Auditory nerve (AuN) in sham operated and compressed (Comp) ears. The 
compression site is marked with a double-arrow. Distal extension of the GFAP domain is 
indicated by arrowheads. Spiral ganglion cells, labeled with Tuj1, were lost following 
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compression (multiple single arrows). Asterisks indicate glial scar processes projecting 
into small bony canals beyond the fundus of the IAC. (C) Fluorescence image of glial 
scar formed 5 weeks after auditory nerve injury, ChABC-treated (upper panels). The 
boxed area is enlarged in lower panels where confocal microscopy disclosed fine glial 
scar processes (arrowheads) past Rosenthal’s canal (R). The margin of the limbus was 
non-specifically stained (arrows). bsl, mdl, ap - basal, middle, apical cochlear turn, 
respectively. (D) Expression of GFAP. PPA, positive pixel area (n=4). (E) Western blot 
for GFAP. (F) Relative expression of GFAP mRNA after 1, 4 and 25 weeks. (G) 
Expression of 1G2 (Neurocan) (n=4). (H) Relative expression of Neurocan mRNA. (I) 
Relative expression of Nestin mRNA. (J) Nestin expression at compression site. Most of 
the glial scar processes were Nestin-positive (arrowheads) and some were GFAP-positive 
(arrows). The boxed area in the left panel is enlarged in the right. The asterisk indicates 
tissue loss due to compression injury. (K) The ChABC-digested auditory nerve was 2B6-
positive (n=4). Scale bars, 200 μm in B, C upper, 100 μm in J, 20 μm in C lower, D, G, 
K. All values represent mean ± SD. *p<0.05, **p<0.01, ***p<0.001. 
 
Figure 2. Recovery of ABRs after intra-neural and surface transplantation of cells. 
A-C: Auditory evoked brainstem responses (ABRs) before compression (A), 5 weeks 
after compression before cell transplantation (B) and 3 months after intra-neural cell 
transplantation (C). Arrowhead in C, monophasic positive potential indicating electrical 
failure of nerve impulse transmission. D-F: ABRs before compression (D), 5 weeks after 
compression (E), and 3 months after surface transplantation (F). G-I: Amplitudes (G) and 
threshold values (H) of wave III, before (blue) and 3 months after cell transplantation 
(red). (I) Latency of wave III before and after cell transplantation (n=10).  
 
Figure 3. Donor cells after intra-neural (A-B) and surface delivery (C-M).  
(A) Intra-neurally transplanted cells died within 2 months of transplantation and cell 
debris (arrows) was found scattered within the nerve, mainly in the site of delivery 
(oblique bar). Arrowheads indicate glial scar processes projecting into small bony canals 
beyond the fundus of the internal auditory canal. AuN, auditory nerve. (B) GFP+ Tuj1+ 
cell debris was observed (arrows) within the cavity (*) formed after compression injury. 
(C-D) Layers of transplanted cells (arrows) were attached to the surface (dotted line) of 
the auditory nerve (AuN) (C) and brainstem (BS) (D). (E) A group of cells (arrowhead 
and arrows) inside the auditory nerve 3 months after cell transplantation. (F-G) Chains of 
donor cells (arrows) entered the auditory nerve from its surface (dotted lines) and others 
were aligned within a conduit-like structure in the glial scar (H-I). The arrowed area in H 
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is enlarged in I. (J) In the proximal portion of the glial scar (rectangle 1), transplanted 
cells (arrows in K) were loosely surrounded by hypertrophic, astrocytic processes 
(arrowheads in K) and apparently continued to migrate distally within the scar (rectangle 
2 in J, L). Boxed areas 1 and 2 in J are enlarged in following panels K and L, respectively. 
Arrowhead in L indicates a cell outside the nerve. Oblique bar in J indicates the site of 
compression. (M) GFP+ transplanted cells (arrows) were abundant as observed in L. L 
and M are approximately adjacent sections. Scale bars, 200 μm in A, H, J, 50 μm in B, 
25μm in C, 20 μm in F, I, D, E, M, L, 10 μm in K. 
 
Figure 4. Glia- and neuron-guided migration of transplanted cells. (A, B) 
Transplanted cell (arrows) intimately related to GFAP+ process (arrowheads). (C) 
Transplanted cells among elongated glial scar processes. The boxed area is enlarged in 
(D-E). # - cavities at the compression epicenter, * - dead cells embedded into glial scar 
tissue. (D, E) Bipolar cells (arrows) formed chains within GFAP+ sheaths (arrowheads). 
(F) GFP+ Tuj1+ cell (arrow) attached to residual neurons (arrowheads). (G) The glial scar 
spread throughout the auditory nerve. The boxed area is enlarged in (H-I). (H) 
Transplanted cells (*) appeared to use neurons (arrowheads) for guidance. (I) GFP+ cells 
(arrows) in approximately the same area as in H. Arrowheads indicate GFP+ processes 
and triple arrows in left upper corner bipolar processes. (J-L) A gliotic area in auditory 
nerve (Boxed in J) is enlarged in K-L. One residual neuron (arrowheads in K, L) in a 
region of dense anisomorphic glial scar was apparently used by a transplanted cell (arrow 
in L) as the guide. Confocal imaging (L) disclosed a cell that was not identified by 
fluorescence microscopy (circle in K). Asterisks, tissue loss due to mechanical 
compression. (M) GFP+ cells (arrows) attached to Tuj1+ residual axon (arrowheads) in 
tandem. M is several sections apart from L, and roughly corresponds to upper part of L. 
Scale bars, 200 μm in G, J, 100 μm in C, 25 μm in F, 20 μm in A, H, I, 15 μm in K, L, M, 
10 μm in D, E, 8 μm in B.  
 
Figure 5. Regenerating neurites in Rosenthal canal. Bundle of GFP+ Tuj1+ neurites 
(arrowheads) projecting through Rosenthal’s canal (R) to the habenula perforata (#). bsl, 
basal cochlear turn, OSL, osseous spiral lamina. Scale bars, 150 μm in left, 50 μm in right. 
 
Figure 6. Distal and proximal synaptic formations of the transplanted cells. (A) Co-
localization of label for GFP and GluR2/3 at the base and perinuclear region of an inner 
hair cell (arrowheads). The asterisk indicates a GluR2/3+ spot expressed perinuclearly. 
The dotted line indicates an inner hair cell. ap, apical cochlear turn, mdl, middle cochlear 
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turn. The boxed area shows location of adjacent panels. (B) Multiple GFP+ neurites in 
the brainstem (arrows), including one (double arrows) that reached a CN cell with co-
localization of synaptophysin. (C) GFP+ synaptophysin+ cells (arrows) in rats with 
improved ABRs. Their morphology is reminiscent of endbulbs of the auditory nerve. The 
arrow in the left panel indicates the anterior direction. The small circle with the arrowhead 
in the left panel in B and C is the approximate location in the posteroventral cochlear 
nucleus (PVCN) that is enlarged in the following panels. Dotted lines in B and C indicate 
the surface of the brainstem. (D) Number of GFP+ synaptophysin+ cells in rats with and 
without ABR improvement in the PVCN (5 rats with ABR improvement; 4 rats without 
ABR improvement). AuN, auditory nerve, BS, brainstem. ** p < 0.01. Scale bars, 400 
μm in left in B, C, 200 μm in left in A, 10 μm in right in A, B, C. 
 
Figure 7. Numbers of surface transplanted cells and spiral ganglion cells (SGC) in 
rats with and without ABR improvement. (A-C) Three months after cell 
transplantation, donor cells were abundant within the auditory nerve trunk (arrowheads 
in A, B), and at the fundus and along the wall of the internal auditory canal (IAC) 
(arrowheads in C) in rats with improved ABRs. These cells aggregated as observed in 
Rosenthal’s canal (areas 1, 2 in C). The boxed areas in A-C are enlarged in each adjacent 
panel. The dotted line in C is the fundus and wall of the IAC. (D) The number of eGFP+ 
transplanted cells was significantly larger in the rats with improved ABRs than in those 
without. The survival rate of transplanted cells in the rats with ABR improvement was 
13.7% of total transplanted cells. (E) Residual spiral ganglion cells in basal, middle, and 
apical cochlear turns of sham treated and treated rats without ABR improvement are 
shown. Arrows indicate residual spiral ganglion cells in middle cochlear turns. (F) There 
was no significant difference in the residual numbers of endogenous SGCs between the 
rats with and without improved ABRs. Approximately 83-87% of SGCs degenerated after 
auditory nerve injury. The data is from 4 sham-operated rats, 6 rats with ABR 
improvement and 4 rats without ABR improvement. AuN, auditory nerve. Scale bars, 500 
μm in left panels of A-C, 50 μm in right panels of C, E, 40 μm in right panels of A, B. 
*p<0.05, ***p<0.01, ****p<0.001. 
 
Figure 8. ELISA of ChABC-treated and untreated auditory system after 
compression and entry of donor cells from the surface of the auditory nerve. (A) 
Significantly higher concentration of BDNF in ChABC-treated samples (Comp + 
ChABC) relative to untreated samples (Comp). **p<0.01. (B-E) GFP+ transplanted cells 
(arrows) entering the auditory nerve (AuN) from the surface (dotted lines) were TrkB-
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Supporting Information Methods 
Immunohistochemistry 
Temporal bones were decalcified with 10% ethylenediaminetetraacetic acid (EDTA) and 
HCl solution (pH 7.4) at 30°C for 5 weeks using a microwave processor (MI-33, 
Azumaya corporation, Japan). Serial 15 µm frozen sections were made by a cryostat 
(Leica CM1850, Leica Biosystems) after embedding into OCT compound. After blocking 
in the mixture of 10% normal goat serum (NGS) in PBS and 2% bovine serum albumin 
in PBS, sections were incubated in primary antibody diluted in 10% NGS overnight at 
4°C. The targets of the following primary antibodies are as follows (Fig. S1C); anti-EGFP 
rabbit serum (1:500; Molecular Probes), anti-GFP rat monoclonal antibody (1:10,000, 
Nakalai tesque), anti-GluR 2/3 rabbit polyclonal (1:100, Millipore), anti-synaptophysin 
mouse monoclonal (1:100, BD Transduction laboratories), anti-beta III-tubulin mouse 
monoclonal antibody (Tuj1, 1:500, Covance Research Product), anti-neurofilament (NF) 
chicken polyclonal antibody (1:500 or 1000, Chemicon), anti-GFAP rabbit polyclonal 
antibody (1:500; DAKO), anti-neurocan mouse monoclonal antibody (1G2, 1:500, 
Seikagaku), anti-TrkB rabbit polyclonal (sc-12, 1:500, Santa Cruz Biotechnology), anti-
nestin mouse antibody (1:500, BD Pharminogen), mouse monoclonal 2B6 antibodies 
(1:500, Seikagaku) and anti-myosin 7a rabbit polyclonal (1:500, Proteus Biosciences). 
The next day, the sections were washed extensively with PBS and incubated in the 
appropriate secondary antibodies, Alexa Fluor 488, 546, 568, 633 (1:500, Molecular 
Probes) and Cy3-conjugated IgG (1:500, Jackson Immunoresearch Laboratories). For 
nuclear staining, 4',6-diamidino-2-phenylindole (DAPI; 2 µg/ml, Molecular Probes) was 
applied. After extensive washing, the sections were mounted, coverslipped and viewed 
by a fluorescence microscope and confocal laser-scanning microscopes (TCS-SPE and 
SP8, Leica Microsystems). Sections incubated without the primary antibodies were used 
to confirm they were free of immunofluorescence. Images were processed with 
Photoshop (CS3, 6, Adobe Systems) for the figures. Adjustments of brightness and 
contrast were equally applied across the entire images. Immunostaining with antibodies 
2B6 and GluR2/3 were weakened considerably after fixation and decalcification. To 
avoid such attenuations, 2B6 was applied to the auditory nerves excised from the 
perfusion-fixed specimens without decalcification. However, in synaptic labelling with 
GluR2/3, we had no choice but to use fixed and decalcified samples. Both experimented 
and sham samples were processed at the same session.  
Sample collection for Western blotting, qRT-PCR and ELISA studies 
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We first traced the facial nerve that was situated antero-superior to the vestibulocochlear 
nerve from the internal auditory meatus (IAM) to the brainstem by inserting a nerve hook 
(No.10030-13, Fine Science Tools, Inc. Canada) between them and the facial nerve was 
entirely separated and removed. Next, the vestibular portions of the 8th cranial nerve were 
identified posterior to the auditory nerve and removed. With these procedures the auditory 
nerve was entirely observed from the IAM to the brainstem. On the brainstem, 
ventral/dorsal cochlear nuclei were recognized as a prominent tubercle and were peeled 
from the brainstem. Next, the nerve hook was inserted to the fundus of the internal 
auditory canal and the auditory nerve tissue was scraped out as much as possible. As a 
result, en bloc samples contained large cochlear nucleus tissue with small funnel-shaped 
auditory nerve/root without including tissue from other regions. These samples were used 
for quantification of glial scar formation in the cochlear nucleus and auditory nerve. 
 
Western blotting of GFAP 
Samples were collected from experimental rats, 4 weeks after compression (right side, 
n=19) and those from sham rats were used as control. Total protein was extracted by 
homogenizing and sonicating the tissue in RIPA buffer (Sigma). After centrifugation of 
the homogenate at 1,000×g and 4 °C, the supernatant was resolved in a buffered solution, 
consisting of SDS, Tris-HCl and proteinase inhibitor (Cell signaling) and boiled at 98°C 
for 2 min. after adding 2-mercaptoethanol. Proteins were separated on a SuperSep Ace 
gel (Wako) and subsequently transferred into PVDF membrane (GE Healthcare). 
Membranes were blocked for 1 hour in 5% BSA and probed with GFAP antibody 
(1:15,000, Dako, rabbit polyclonal) overnight. As the secondary antibody, horseradish 
peroxidase-linked anti-rabbit IgGs (1:10,000, GE Healthcare) were applied. Proteins were 
visualized with Amersham ECL Prime Western Blotting Detection Reagent (GE 
Healthcare) according to the manufacturer's instructions. Blots were also probed for 
GAPDH as a loading control. Single membrane simultaneously including lanes of injured 
and control samples and molecular size markers side-by-side were used for evaluation. 
 
qRT-PCR 
The samples were collected from the rats 1, 4, and 25 weeks after compression (15 rats 
for each time point) and immersed in ice cold solution of protease inhibitor/RIPA buffer 
and stored in liquid nitrogen until homogenization. The samples were collected in a 
solution with buffer RLT with 1% 2-mercaptoethanol and homogenized with a QIA 
shredder homogenizer (Qiagen). Total RNA was extracted by using an RNeasy Mini Kit 
(Qiagen). Prior to the reverse transcription reaction, potentially contaminating residual 
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genomic DNA was eliminated by Turbo DNase (Ambion). We used a High Capacity 
cDNA synthesis kit (Applied Biosystems) to synthesize single-stranded cDNA. The RT 
reaction conditions were as follows: 25 °C  for 10 min, 37 °C for 120 min, 85 °C  for 
5 sec. Real-time PCR was performed using an ABI prism 7000 (Applied Biosystems). 
The PCR reaction sample was prepared as a mixture of 7.5ul of 2× Taqman Universal 
PCR Master mix (Applied Biosystems), 0.75ul of 20× Taqman Gene Expression Assays 
and 6.75ul of the properly diluted cDNA. The expression level of each gene was 
normalized with a control TaqMan probe (GAPDH). Real-time PCR primers and probes 
were obtained from Applied Biosystems (CSPG3, Neurocan, Rn00581331_m1; GFAP, 
Rn00566603_m1; Nestin, Rn00564394_m1). Amplification was performed with a 
program of 50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles 95 °C for 15 sec, 
60 °C for 1 min. The data were acquired in triplicate. Gene expression values, normalized 
to GAPDH expression, were determined by using the comparative Ct method (ΔΔCt 
method). The abundance of each transcript was expressed relative to the levels in auditory 
nerve/cochlear nucleus in sham rats.  
 
ELISA 
ELISA was performed by staff at MACROPHI Inc. (http://macrophi.co.jp/english/) who 
had no information about the categories of the samples. Samples collected from 30 rats 
(5-10 weeks after compression) and stored at −80 °C were quickly thawed and diluted to 
1:10 w/v with the buffer containing 100mM Tris–HCl (pH 7.2), 400mM NaCl, 
4mMEDTA, 0.05% sodium azide, 0.5% gelatin, 0.2% Triton-X 100, 2% BSA, and 
complete protease inhibitor cocktail. The samples were homogenized under ice-cold 
condition and the homogenates were centrifuged (11,000×g, 20min, 4 °C). The 
supernatant was collected and ELISA study was performed for quantification of 
endogenous BDNF with a Promega BDNF Emax ImmunoAssay System following the 
manufacturer’s instructions. Briefly, 96-well immunoplates were coated with 100 μl/well 
of monoclonal anti-BDNF mouse antibody and incubated overnight at 4 °C. Non-specific 
binding was blocked with Block and Sample buffer. Then the samples and standards in 
duplicate were added to the coated wells (100 μl each) for 2 h at RT. After 2 h, the antigen 
was incubated with polyclonal anti-human BDNF antibody for 2 h at RT and then 
incubated with an anti-IgY HRP for 1 h at RT. The addition of 3,3’,5,5’-
tetramethylbenzidine started the colour reaction. The reaction was stopped 10 min later 
with 1M HCl solution, and the absorbance was immediately measured at 450 nm with 
correction between 750 nm (BIO RAD model 680 Microplate reader, Bio-Rad 
Laboratories).  
Legends for Supplementary Figures 
 
Figure S1. Techniques to induce glial scar in rat auditory system, to transplant 
donor cells to gliotic auditory nerve and the primary andibodies used in this study. 
(A) Operative view of auditory nerve compression in the cerebellopontine angle (CPA). 
Red circle correspondes that in Fig. 1A. Fundus, fundus of the internal auditory canal; 
IAM, internal auditory meatus; PB, petrous bone. (B) Donor cells were transplanted to 
gliotic auditory nerve by two different techniques, intra-neural method (1) and surface 
transplatnation method (2). The tips of the syringe needles are indicated by circles. (C) 
Primary antibodies used to identify relevant endogenous and exogenous components of 
the auditory system (SI Methods). 
 
Figure S2. Neural generators of ABR and ABR waveform changes after surgical 
ablation of cochlear nucleus tissue and auditory nerve injury/subsequent glial scar 
formation. (A) In small experimental animals including rat, wave I of ABR is generated 
from the auditory nerve and wave II, III, IV and V mainly reflect synaptic activities in the 
cochlear nucleus, superior olivary complex, lateral lemniscus and inferior colliculus, 
respectively. (B) Acute experiment to remove a part of the cochlear nucleus with a sucker 
depressed wave II and the following waves markedly while wave I maintained, 
confirming wave II was generated from the cochlear nucleus. Note the amplitude of wave 
I was not attenuated at this moment. (C) Normal configuration of ABR waveform was 
lost by auditory nerve mechanical injury and subsequent glial scar formation (dotted box 
in A). After compression, wave III was observed more apparently because of attenuation 
of wave II, the most prominent peak in small animal ABR. Measurements of wave III 
amplitudes and latencies are shown by blue perpendicular lines and red horizontal bi-
directional arrows, respectively. Attenuation of wave I amplitude 5 weeks after auditory 
nerve injury was probably due to retrograde and Wallerian degenerations of auditory 











Table S1. Raw data of wave III amplitude (A), threshold (B) and latency (C) of 10 
rats that demonstrated ABR improvement after cell transplantation 
 
(A) 




III amp          
(μV) 
 Pre Post Pre Post Pre Post Pre Post Pre Post 
4 kHz 1.146 3.014 2.446 3.467 0.840 3.310 1.598 1.673 1.210 3.032 
8 kHz 1.043 5.124 2.783 4.892 2.561 4.438 2.170 2.556 3.373 6.661 
16 kHz 0.452 2.883 2.174 3.273 1.428 2.533 0.964 1.174 2.476 3.574 
 




III amp          
(μV) 
 Pre Post Pre Post Pre Post Pre Post Pre Post 
4 kHz 2.030 3.093 2.309 3.739 0.807 3.313 1.378 1.452 1.783 2.205 
8 kHz 1.706 2.810 2.701 5.056 3.938 4.262 1.978 5.391 3.327 5.826 
16 kHz 1.360 1.667 1.534 3.429 1.672 4.016 0.891 2.756 2.349 2.943 
 
(B) 
Rat  1 2 3 4 5 
 
 
Threshold            
(dB SPL) 
 pre post pre post pre post pre post pre post 
4 kHz 55 45 45 45 45 35 55 45 45 35 
8 kHz 55 35 45 35 45 25 65 45 45 35 
16 kHz 55 35 55 45 55 45 75 55 55 45 
 




Threshold            
(dB SPL) 
 pre post pre post pre post pre post pre post 
4 kHz 55 45 45 35 45 45 45 45 45 45 
8 kHz 55 45 55 35 45 45 45 35 45 35 









Rat  1 2 3 4 5 
  Pre Post Pre Post Pre Post Pre Post Pre Post 
 
Wave III  
latency 
(ms) 
4 kHz 4.075 4.050 4.100 3.950 3.950 4.075 4.050 4.025 4.100 4.075 
8 kHz 4.175 4.075 4.150 4.100 5.675 5.675 4.125 4.025 4.100 4.125 
16 kHz 4.175 4.150 4.300 4.200 4.200 4.200 4.400 4.150 4.225 4.225 
 
Rat  6 7 8 9 10 
  Pre Post Pre Post Pre Post Pre Post Pre Post 
 
Wave III  
latency 
(ms) 
4 kHz 4.025 4.225 3.975 4.000 4.250 4.250 4.125 4.050 4.050 3.975 
8 kHz 4.125 4.250 4.075 4.025 6.225 5.925 4.200 4.025 4.125 3.975 
16 kHz 4.200 4.300 4.200 4.100 4.400 4.325 4.225 4.100 4.300 4.100 
Amp, Amplitude; Pre, 5 weeks after auditory nerve compression and before cell 
transplantation; Post, 3 months after cell transplantation. 
 
 
 
